PLA2G7 and atherosclerosis: Given that Lp-PLA2 activity has been previously designated as a biomarker for atherosclerosis (47), we considered the possibility that different levels detected in Lp-PLA2 activity between SS-L and SS could be influenced by different levels of atherosclerotic burden or traditional risk factors for atherosclerosis.